Construction of safe and effective live tuberculosis vaccines
Construction of safe and effective live tuberculosis vaccines
批准号:
8083413
负责人:
Steven A Porcelli
金额:
$41.5万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2016-02-29
关键词:
AddressAdjuvantAnimalsAntigen PresentationAntigensApoptosisApoptoticAttenuatedAttenuated VaccinesBacillus (bacterium)BacteriophagesCD4 Positive T LymphocytesCD8B1 geneCellsChemicalsCommunicable DiseasesCosmidsDiseaseGene DeletionGene MutationGenesGeneticGoalsGrowthHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumanImmuneImmune responseImmunityImmunologic Deficiency SyndromesImmunologyIn VitroLaboratoriesLeadLifeLinkMHC Class II GenesMediatingMetabolicMethodologyMulti-Drug ResistanceMusMutagenesisMutationMycobacterium smegmatisMycobacterium tuberculosisPhagocytesPopulationPost-Translational Protein ProcessingPreventionProductionProtein SubunitsProteinsResearch PersonnelRodentScreening procedureSpecificitySystemT cell responseT memory cellT-LymphocyteT-Lymphocyte EpitopesT-Lymphocyte SubsetsTNF geneTestingTuberculosisTuberculosis VaccinesVaccinationVaccinesVirulenceWorkauxotrophycytokinedesign and constructionhuman diseaseimmunogenicimmunogenicityimprovedin vivointerestmortalitymouse modelmutantmycobacterialnoveloverexpressionpathogenpre-clinicalpreventresistant strainresponsevaccine candidatevaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks to understand in greater detail the mechanisms by which Mycobacterium tuberculosis blocks the priming of effective host immunity, with the ultimate goal of using this information to create more effective live vaccine strains. Previous work identified multiple mycobacterial genes involved in blocking apoptosis of infected host cells, which is intimately linked to the ability of the pathogen to prevent presentation of its antigens by MHC class I. Extensive preliminary work has also identified genes in M. tuberculosis that interfere with MHC class II antigen presentation, and genes that block production of key cytokines. A major goal of this proposal is to construct safely attenuated strains of M. tuberculosis in which specific immune evasion genes have been deleted, thus creating more effective vaccines for priming of anti- mycobacterial immunity. The approach involves identifying the most potent anti- apoptotic genes from a group of four candidates that have already been partially characterized, and combining mutations in these with strongly attenuating auxotrophy mutations to eliminate virulence. Precise mutations in the genes of interest will be created using allelic exchange mediated by specialized transducing phages, a methodology that is well established in the laboratory of the PI and his collaborators. The potency of candidate vaccine strains will be further enhanced by incorporating additional mutations in genes that interfere with MHC class II presentation, or with production of IL-12p70 or TNF. Immunological studies of CD4 and CD8 T cell priming by candidate vaccine strains will be carried out in mouse models, allowing identification of the most favorable combinations of specific gene deletions to advance into preclinical vaccination studies in rodents. Studies of the induction of stable T cell memory by candidate vaccine strains will be performed in mice, and the impact of boosting primary responses with mycobacterial proteins will also be initiated. Overall, the proposed studies will significantly advance our understanding of the host-pathogen interaction in tuberculosis, and contribute directly to vaccine development for prevention and control of this major human disease.
PUBLIC HEALTH RELEVANCE: This proposal aims to understand in greater detail the mechanisms by which Mycobacterium tuberculosis evades host immunity to cause serious disease and mortality. The information gained will be applied to the design and construction of better vaccines for the prevention of tuberculosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Flow Cytometery and Cell Sorting Core
-
批准号:10659181
-
项目类别:
-
资助金额:$21.09万
-
财政年份:2022
-
负责人:Steven A Porcelli
-
依托单位:
Flow Cytometery and Cell Sorting Core
-
批准号:10408970
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2022
-
负责人:Steven A Porcelli
-
依托单位:
Bigfoot Multispectral High Speed Fluorescence Activated Cell Sorter
-
批准号:10414835
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2022
-
负责人:Steven A Porcelli
-
依托单位:
"Determinants of T Cell Immunity to Tuberculosis Vaccines"
-
批准号:8871648
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2015
-
负责人:Steven A Porcelli
-
依托单位:
Flow Cytometry Core
-
批准号:8871652
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2015
-
负责人:Steven A Porcelli
-
依托单位:
Construction of safe and effective live tuberculosis vaccines
-
批准号:8230473
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Defining the Correlates of Bactericidal Immunity in Tuberculosis
-
批准号:8031491
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Construction of safe and effective live tuberculosis vaccines
-
批准号:8626351
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
"Determinants of T Cell Immunity to Tuberculosis Vaccines"
-
批准号:8049854
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Defining the Correlates of Bactericidal Immunity in Tuberculosis
-
批准号:8207834
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Construction of safe and effective live tuberculosis vaccines
-
批准号:8431439
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Flow Cytometry Core
-
批准号:8049861
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Construction of safe and effective live tuberculosis vaccines
-
批准号:9132485
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2011
-
负责人:Steven A Porcelli
-
依托单位:
Flow Cytometry Core
-
批准号:7943653
-
项目类别:
-
资助金额:$2.84万
-
财政年份:2010
-
负责人:Steven A Porcelli
-
依托单位:
Digital Extra Parameter (DxP8)
-
批准号:7794342
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:Steven A Porcelli
-
依托单位:
Laser Scanning Cytometer
-
批准号:7595975
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2008
-
负责人:Steven A Porcelli
-
依托单位:
MoFlow High Speed Fluorescence Activated Cell Sorter
-
批准号:7213177
-
项目类别:
-
资助金额:$43.16万
-
财政年份:2007
-
负责人:Steven A Porcelli
-
依托单位:
FLOW CYTOMETRY SHARED RESOURCE
-
批准号:7506847
-
项目类别:
-
资助金额:$13.83万
-
财政年份:2007
-
负责人:Steven A Porcelli
-
依托单位:
Determinants of T Cell Immunity to Tuberculosis Vaccines
-
批准号:6878900
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2004
-
负责人:Steven A Porcelli
-
依托单位:
Core--FACS
-
批准号:6878907
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2004
-
负责人:Steven A Porcelli
-
依托单位:
海外基金